Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles

Journal of Virology

Volumn 80, Issue 11, 2006, Pages 5135-5144

  Johnson, Reed F ^a   McCarthy, Sarah E ^a   Godlewski, Peter J ^a   Harty, Ronald N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; NUCLEOPROTEIN; PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; DNA PACKAGING; EBOLA VIRUS; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO HYBRID SYSTEM; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EBOLAVIRUS; GENOME, VIRAL; NUCLEOPROTEINS; VERO CELLS; VIRAL CORE PROTEINS; VIRUS ASSEMBLY;

EBOLA VIRUS; MAMMALIA;

EID: 33646739525     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01857-05     Document Type: Article

References (33)

1. Basak, X., S. Polley, M. Basu, D. Chattopadhyay, and S. Roy. 2004. Monomer and dimer of Chandipura virus unphosphorylated P-protein binds leader RNA differently: implications for viral RNA synthesis. J. Mol. Biol. 339:1089-1101.
2. Basler, C. F., A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Muhlberger, M. Bray, H. D. Klenk, P. Palese, and A. Garcia-Sastre. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956.
3. Basler, C. F., X. Wang, E. Muhlberger, V. Volchkov, J. Paragas, H. D. Klenk, A. Garcia-Sastre, and P. Palese. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 97:12289-12294.
4. Chen, Z., T. J. Green, M. Luo, and H. Li. 2004. Visualizing the RNA molecule in the bacterially expressed vesicular stomatitis virus nucleoprotein-RNA complex. Structure 12:227-235.
5. Choudhary, S. K., A. G. Malur, Y. Huo, B. P. De, and A. K. Banerjee. 2002. Characterization of the oligomerization domain of the phosphoprotein of human parainfluenza virus type 3. Virology 303:373-382.
6. Coronel, E. C., T. Takimoto, K. G. Murti, N. Varich, and A. Portner. 2001. Nucleocapsid incorporation into parinfluenza virus is regulated by specific interaction with matrix protein. J. Virol. 75:1117-1123.
7. Gomis-Ruth, F. X., A. Dessen, J. Timmins, A. Bracher, L. Kolesnikowa, S. Becker, H. D. Klenk, and W. Weissenhorn. 2003. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure 11:423-433.
8. Groseth, A., H. Feldmann, S. Theriault, G. Mmehmetoglu, and R. Flick. 2005. RNA polymerase 1-driven minigenome system for Ebola viruses. J. Virol. 79:4425-4433.
9. Han, Z., H. Boshra, J. O. Sunyer, S. H. Zwiers, J. Paragas, and R. N. Harty. 2003. Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J. Virol. 77:1793-1800.
10. Hartman, A. L., J. S. Towner, and S. T. Nichol. 2004. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 328:177-184.
11. Harty, R. N., M. E. Brown, G. Wang, J. Hibregtse, and F. P. Hayes. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and funtionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. USA 97:13871-13876.
12. Hoenen, T., V. Volchkov, L. Kolesnikova, E. Mittler, J. Timmins, M. Ottmann, O. Reynard, S. Becker, and W. Weissenhorn. 2005. VP40 octamers are essential for Ebola virus replication. J. Virol. 79:1898-1905.
13. Huang, Y., L. Xu, Y. Sun, and G. J. Nabel. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posstranslational modification of nucleoprotein. Mol. Cell 10:307-316.
14. Jasenosky, L. D., G. Neumann, I. Lukashevich, and Y. Kawaoka. 2001. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J. Virol. 75:5205-5214.
15. Kallstrom, G., K. L. Warfield, D. L. Swenson, S. Mort, R. G. Panchal, G. Ruthel, S. Bavari, and M. J. Aman. 2005. Analysis of Ebola virus and VLP release using an immunocapture assay. J. Virol. Methods 127:1-9.
16. Licata, J. M., R. F. Johnson, Z. Han, and R. N. Harty. 2004. Contribution of Ebola virus glycoprotein, nucleoprotein and VP24 to budding of VP40 virus-like particles. J. Virol. 78:7344-7351.
17. Licata, J. M., M. Simpson-Holley, N. T. Wright, Z. Han, J. Paragas, and R. N. Harty. 2003. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS4. J. Virol. 77:1812-1819.
18. Liu, P., J. Yang, X. Wu, and Z. F. Fu. 2004. Interactions amongst rabies virus nucleoprotein, phosphoprotein and genomic RNA in virus-infected and transfected cells. J. Gen. Virol. 85:3725-3734.
19. Mavrakis, M., L. Kolesnikova, G. Schoehn, S. Becker, and R. W. H. Ruigrok. 2002. Morphology of Marburg virus NP-RNA. Virology 296:300-307.
20. Muhlberger, E., B. Lotfering, H.-D. Klenk, and S. Becker. 1998. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J. Virol. 72:8756-8764.
21. Muhlberger, E., M. Weik, V. E. Volchkov, H. D. Klenk, and S. Becker. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J. Virol. 73:2333-2342.
22. Nanda, S. K., R. F. Johnson, Q. Liu, and J. L. Leibowitz. 2004. Mitochondrial HSP70, HSP40, and HSP60 bind to the 3′ untranslated region of the murine hepatitis virus genome. 149:93-111.
23. Noda, T., H. Sagara, E. Suzuki, A. Takada, H. Kida, and Y. Kawaoka. 2002. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol. 76:4855-4865.
24. Panchal, R. G., G. Ruthel, T. A. Kenny, G. H. Kallstrom, D. Lane, S. S. Badie, L. Li, S. Bavari, and M. J. Aman. 2003. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl. Acad. Sci. USA 100:15936-15941.
25. Peters, C. J., P. Jahrling, T. G. Ksiazek, E. Johnson, and H. Lupton. 1992. Filovirus contamination of cell cultures. Dev. Biol. Stand. 76:267-274.
26. Sullivan, N., Z.-Y. Yang, and G. J. Nabel. 2003. Ebola virus pathogenesis: implications for vaccines and therapies. J. Virol. 77:9733-9737.
27. Tarbouriech, N., J. Curran, C. Ebel, R. W. Ruigrok, and W. P. Beurmeister. 2000. On the domain structure and the polymerization state of the Sendai virus P protein. Virology 266:99-109.
28. Timmins, J., G. Schoehn, C. Kohlhaas, H. D. Klenk, R. W. Ruigrok, and W. Weissenhorn. 2003. Oligomerization and polymerization of the filovirus matrix protein VP40. Virology 312:359-368.
29. Volchkov, V. E., V. Volchkova, A. A. Slenczka, H.-D. Klenk, and H. Feldmann. 1998. Release of viral glycoproteins during Ebola virus infection. Virology 245:110-119.
30. Watanabe, S., T. Watanabe, T. Noda, A. Takada, H. Feldmann, L. D. Jasenosky, and Y. Kawaoka. 2004. Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics. J. Virol. 78:999-1005.
31. Wills, J. W., R. C. Craven, and J. A. Achacoso. 1989. Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J. Virol. 63:4331-4343.
32. Yang, J., D. C. Hooper, W. H. Wunner, H. Koprowski, B. Dietzschold, and Z. Fu. 1998. The specificity of rabies virus RNA encapsidation by nucleoprotein. Virology 242:107-115.
33. Yu, W., and J. L. Leibowitz. 1995. Specific binding of host cellular proteins to multiple sites within the 3′ end of the mouse hepatitis virus genomic RNA. J. Virol. 69:2016-2023.